Liu, Huafeng
Li, Xin
Hu, Li
Zhu, Min
He, Bailin
Luo, Liqun
Chen, Lieping
Article History
Received: 14 February 2017
Accepted: 15 February 2017
First Online: 8 May 2017
Change Date: 23 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41423-023-01038-5
Conflict of interest
: LC serves as an advisor/board member for Pfizer, AstraZeneca, NextCure, GenomiCare and Vcanbio, and receives research support from Boehringer Ingelheim, Pfizer and NextCure. LC also serves as an uncompensated adjunct faculty member of Sun Yat-Sen University. The remaining authors declare no conflict of interest.